Opcon-A Allergy Eye Drops by Bausch + Lomb is one of the best products I ... Some of the best eye drops for red eyes due to allergies are: Alaway Antihistamine Eye Drops Zaditor Antihistamine ...

We highly recommend Opcon-A Allergy Eye Drops by Bausch + Lomb to anyone experiencing red ... from itchy and watery eyes caused by allergies, Alaway Antihistamine Eye Drops might be the solution ...

Bausch Health turned down recent debt-restructuring proposals from bondholders as it explores a sale of its Bausch + Lomb vision care subsidiary that could bring in billions of dollars to pay ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Private equity giants TPG and Blackstone have joined forces to submit a joint bid for eyecare company Bausch + Lomb, Financial Times reported citing sources familiar with the development. If ...

It isn't known whether Bausch + Lomb and/or Goldman is in contact with either Blackstone or TPG. According to the FT, several private equity funds mulling offers have dropped out of the race.

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company. A bid from Blackstone and TPG could reportedly value the company ...

Private equity players TPG and Blackstone are planning a joint bid for Canadian contact lens supplier Bausch + Lomb, Financial Times reported on October 14 citing people familiar with the matter.

Bausch + Lomb rises 12% in premarket trading after reports that Private equity groups TPG and Blackstone have teamed up to work on a joint bid for the eyecare company, according to the Financial Times ...